Calcimedica announces presentations at upcoming medical meetings

Prof. robert sutton to  deliver plenary presentation on phase 2b carpo trial of auxora™ in acute pancreatitis (ap) at american pancreatic association (apa) 2024 annual meeting poster presentation on phase 2b carpo trial at emergencies in medicine (eim) 2024 meeting la jolla, calif. , nov. 20, 2024 /prnewswire/ -- calcimedica inc. ("calcimedica") (nasdaq: calc), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (crac) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced the acceptance of an abstract for plenary presentation at  the american pancreatic association (apa) 2024 annual meeting being held december 9-10 in maui, hi, and the acceptance of an abstract for poster presentation at the emergencies in medicine (eim) 2024 meeting being held december 8-13 in maui, hi.
CALC Ratings Summary
CALC Quant Ranking